Daunorubicin

In the US, Daunorubicin (daunorubicin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Acute Lymphocytic Leukemia, Acute Myeloid Leukemia and Acute Nonlymphocytic Leukemia.

US matches:

• Daunorubicin


• Daunorubicin Liposomal


• Daunorubicin Intravenous


• Daunorubicin citrate liposome Intravenous


• Daunorubicin citrate


• Daunorubicin hydrochloride


• Daunorubicin Citrate Liposomal

UK matches:

• Daunorubicin (sanofi-aventis)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01DB02

CAS registry number (Chemical Abstracts Service)

0020830-81-3

Chemical Formula

C27-H29-N-O10

Molecular Weight

527

Therapeutic Category

Antineoplastic antibacterial

Chemical Names

(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methyloxy-6,11-dioxo-naphtacen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside (BAN)

(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methyloxy-6,11-dioxo-naphtacenyl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside (WHO)

(1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methyloxy-6,11-dioxo--1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-tridesoxy-α-L-lyxo-hexopyranoside (IUPAC)

Foreign Names

• Daunorubicinum (Latin)
• Daunorubicin (German)
• Daunorubicine (French)
• Daunorubicina (Spanish)

Generic Names

• Daunorubicin (OS: BAN)
• Daunorubicina (OS: DCIT)
• Daunorubicine (OS: DCF)
• Daunomycin (IS)
• DNR (IS)
• FI 6339 (IS)
• NSC 82151 (IS)
• RP 13057 (IS)
• Rubidomycin (IS)
• Daunorubicin, liposomal (IS)
• Daunorubicin Hydrochloride (OS: USAN, BANM)
• NDC 0082-4155 (IS)
• Daunorubicin Hydrochloride (PH: BP 2010, USP 32, Ph. Eur. 6)
• Daunorubicine (chlorhydrate de) (PH: Ph. Eur. 6)
• Daunorubicinhydrochlorid (PH: Ph. Eur. 6)
• Daunorubicini hydrochloridum (PH: Ph. Eur. 6)

Brand Names

• Cerubidine
  Aventis, Luxembourg; Sanofi-Aventis, Israel



• Daunocin
  Korea United Pharm, Georgia



• Daunorubicina
  GP Pharm, Peru; World Pharma, Peru



• DaunoXome
  Gilead, United States



• Daurocina
  Chile, Chile



• DaunoXome
  Diatos, Denmark; Diatos, United Kingdom



• Cerubidin Orifarm
  Sanofi-Aventis, Denmark



• Cerubidin
  Sanofi-Aventis, Ireland; Sanofi-Aventis, Norway; Sanofi-Aventis, Sweden



• Cerubidine
  Bedford, United States; Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Chile; Sanofi-Aventis, Netherlands; Sicor, United States



• Cérubidine
  Sanofi-Aventis, France



• Daunoblastin
  Pfizer, Austria; Pfizer, Bosnia & Herzegowina; Pfizer, Germany; Pfizer, South Africa



• Daunoblastina
  IFET, Greece; Pfizer, Argentina; Pfizer, Bahrain; Pfizer, Brazil; Pfizer, Estonia; Pfizer, Spain; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Italy; Pfizer, Peru; Pfizer, Romania; Pfizer, Singapore; Pfizer, Taiwan; Pfizer, Venezuela; Pfizer, Vietnam; Pharmacia, Serbia



• Daunomicina
  Deva, Turkey



• Daunomycin
  Meiji Seika Kaisha, Japan; Pharmacia & Upjohn, Sri Lanka



• Daunorrubicina
  Bestpharma, Chile



• Daunorubicin hydrochloride
  Bedford, United States; Hospira, New Zealand; Teva USA, United States



• Daunorubicin Pfizer
  Pfizer, Singapore



• Daunorubicin
  PfizerPerth, Australia



• DaunoXome
  Gilead, France; Gilead, Ireland; Nexstar, Greece



• Maxidauno
  Varifarma, Argentina



• Oncodaunotec
  Biotoscana, Chile; Biotoscana, Colombia



• Rubilem
  Lemery, Peru

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.